Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...

Fact checked by Jennifer Klump GLP-1 drugs may increase the risk of a severe form of macular degeneration in older adults with diabetes, according to a recent study published in JAMA Ophthalmology. A ...

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...

It is administered intravenously, unlike current treatments, which need injections into the eye. Read more at ...

Age-related macular degeneration (AMD) can lead to feelings of anxiety and depression. Here’s what to watch for and how to safeguard your mental health. Skip to main content ...